|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02096 SIMCERE PHARMA
Nominal 
11.680 -0.400 (-3.311%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 4,580,142 | 27.762% | 3,584,912 | 3,113,524 | 3,381,695 | 2,699,650 |
| Cost of Sales | (765,105) | 10.714% | (691,062) | (651,592) | (820,358) | (557,371) |
| Gross Profit | 3,815,037 | 31.833% | 2,893,850 | 2,461,932 | 2,561,337 | 2,142,279 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (2,555) | 1376.879% | (173) | 591 | 393 | (334) | |
| Profit / (Loss) before Taxation | 966,718 | 46.488% | 659,930 | 494,693 | 2,324,219 | 52,523 | |
| Taxation | (140,182) | 138.089% | (58,878) | (38,093) | (51,346) | 9,398 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 2,184 | -- | 0 | 0 | 811 | 1,863 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 828,720 | 37.878% | 601,052 | 456,600 | 2,273,684 | 63,784 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 832 | -96.210% | 21,955 | (1,942) | (12,780) | (11,746) |
| Depreciation & Amortisation | 208,613 | 18.581% | 175,924 | 161,248 | 150,605 | 134,150 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 32.000 | 28.000% | 25.000 | 18.000 | 87.000 | 2.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 3.670 | -- | 2.923 | 2.716 | 3.398 | 2.315 |
| Remarks: | Real time quote last updated: 24/08/2026 09:57 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 828,720 |
| %Change | 37.878% |
| EPS / (LPS) | RMB 0.320 |
| NBV Per Share (¥) | RMB 3.670 |